eXoZymes Inc.
EXOZ | NASDAQ
$4.11
-$0.20 (-4.64%)
At close: Nov 5, 2026, 4:00 PM ET
$4.15
+$0.04 (+0.97%)
After-hours:
Nov 5, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 267.38K | n/a | 147.75K | 59.41K |
Gross Profit | n/a | -267.38K | n/a | -147.75K | -59.41K |
Operating Income | -9.72M | -5.93M | -1.8M | -1.33M | -1.29M |
Interest Income | n/a | 77.61K | 100 | 98 | n/a |
Pretax Income | -9.26M | -5.86M | -2M | -1.33M | -1.21M |
Net Income | -9.16M | -5.86M | -2.04M | -1.4M | -1.21M |
Selling & General & Admin | 5.91M | 3.8M | 1.34M | 836.83K | 778.99K |
Research & Development | 3.71M | 1.87M | 527.48K | 348.08K | 454.45K |
Other Expenses | 95.99K | n/a | -70.07K | n/a | n/a |
Operating Expenses | 9.72M | 5.66M | 1.8M | 1.18M | 1.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.72M | 5.93M | 1.8M | 1.33M | 1.29M |
Income Tax Expense | -105.21K | n/a | 42.27K | 63.56K | n/a |
Shares Outstanding (Basic) | 8.38M | 8.13M | 8.13M | 8.13M | 8.13M |
Shares Outstanding (Diluted) | 8.38M | 8.13M | 8.13M | 8.13M | 8.13M |
EPS (Basic) | -1.09 | -0.72 | -0.25 | -0.17 | -0.15 |
EPS (Diluted) | -1.09 | -0.72 | -0.25 | -0.17 | -0.15 |
EBITDA | -8.98M | -5.59M | -1.8M | -1.18M | -1.15M |
EBIT | -9.26M | -5.86M | -2M | -1.33M | -1.21M |
Depreciation & Amortization | 287.96K | 267.38K | 196.94K | 147.75K | 59.41K |
Add to Watchlist
Select watchlists to add or remove EXOZ